维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Orlowski R"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies显示文摘	Orlowski R Z Stinchcombe T E Mitchell B S	2002	J Clin Oncol2002，20，：	1
2	NF-kappaB as a therapeutic target in cancer显示文摘	Orlowski R Z Baldwin AS	2002	Trends Mol Med2002，，：	1
3	Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosns T lymphocytes 显示文摘	Orlowski R J O'Rourke KS Olorenshaw I	2008	Immunology2008，125，3：	1
4	Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis显示文摘	ORLOWSKI R Z SMALL G W SHI Y Y	2002	J Biol Chem2002，277，27：	1
5	Targeting the proteasome as a therapeutic strategy against haematological malignancies显示文摘	Orlowski R Z Zeger E L		0，，：	1
6	Proteasome inhibitors in cancer therapy显示文摘	Orlowski R Z Kuhn D J Lessons from the first decade		0，，：	1
7	NF-B as a therapeutic target in cancer显示文摘	ORLOWSKI R Z BALDWIN A S	2002	Trends Mol Med2002，8，8：	1
8	Phase Ⅰ trial of the proteasome inhibitor hortezomib and pegytated liposomal doxorubiciri in patients with advanced hematologic malignancies 显示文摘	Orlowski R Voorhees PM Garcia RA	2005	Blood2005，105，8：	1
9	Phase I trial of the proteasome inhibitor bortezomib and pegylated liposomal doxo-rubicin in patients with advanced hemato-logic malignancies显示文摘	Orlowski R Z Voorhees P M Garcia R A	2005	Blood2005，105，8：	1
10	Measuring audito- rium seat absorption 显示文摘	Davies W J Orlowski R J Lam Y W	1994	The Journal of the Acoustical Society of America1994，96，2：	1
11	Light induced charge transport in doped LiNbO3 and LiTaO3 显示文摘	ORLOWSKI R	1980	Ferroelectrics1980，27，4：	1
12	Experimental study of the effects of different stapling devices in healing of the mechanically sutured bronchial stump显示文摘	Dziedzic D Orlowski TM Jakimiuk R	2000	Eur J Cardiothorae Surg2000，17，2：	1
13	Proteasome inhibitors in cancer therapy: lessons from the first decade 显示文摘	Orlowski R Z Kuhn D J	2008	Clin Cancer Res2008，14，：	1
14	Second generation proteasome inhibitors: carfilzomib and immunoproteasome- specific inhibitors (IP- Sis) 显示文摘	Kuhn D J Orlowski R Z Bjorklund C C	2011	Curr Cancer Drug Targets2011，11，1：	1
15	Randomized phase III study of pagylated liposomal doxorubicin plus bortezomib compared with bortem?mib alone in relapsed or mfractary multiple myeloma: combination therapy improves time to progression显示文摘	ORLOWSKI R Z NAGLER A SONNEVELD p	2007	J Clin Oncol2007，25，：	1
16	Assessment of in vitro cellular responses of monocytes and keratinocytes to tannic acid modified silver nanoparticles 显示文摘	Orlowski P Krzyzowska M Zdanowski R	2013	Toxicol In Vitro2013，27，：	1
17	The ubiquitin proteasome pathway frombench to bedside显示文摘	Orlowski R Z	2005	Hematology Am Soc HematolEduc Program2005，2005，：	1
18	Proteasome inhibitors induce a p38 mitogenactivated protein kinase (MAPK)-dependent antiapoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer显示文摘	SHI Y Y SMALL G W ORLOWSKI R Z	2006	Breast Cancer Res Treat2006，100，1：	1
19	Sensors and regulators of intraccllular pH显示文摘	CASEY J R GRINSTEIN S ORLOWSKI J	2010	Nat Rev Mol Cell Biol2010，11，1：	1
20	A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease显示文摘	BLUMENFIELD M ORLOWSKI B	2006	Cardiol Rev2006，14，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示